Advanced search
Publication Cover
Journal of Chemotherapy Volume 6, 1994 - Issue 2
Submit an article Journal homepage
2
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Combination Chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomycin C in the Palliative Treatment of Locally Advanced and/or Metastatic Adenocarcinoma of the Stomach

V. GebbiaChair and Service of Chemotherapy, Institute of Pharmacology
,
A. TestaChair and Service of Chemotherapy, Institute of Pharmacology
,
R. ValenzaChair and Service of Chemotherapy, Institute of Pharmacology
,
M. LatteriDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
G. BajardiDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
G. MastrandreaDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
C. CipollaDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
G. PischeddaDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
G. CurtoDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
,
G. CannataChair and Service of Chemotherapy, Institute of Pharmacology
,
N. GebbiaChair and Service of Chemotherapy, Institute of Pharmacology
&
M. FlorenaDepartment of Anatomy and Surgery, Polyclinic, University of Palermo, Italy
 show all
Pages 147-151 | Published online: 15 Jul 2016

References

  • Weed TE, Neussle WR, Ochsner A. Carcinoma of the stomach: why are we failing to improve survival? Ann Surg 1981; 193: 407–413.
  • Douglass AO, Nava HR. Gastric adenocarcinoma - management of the primary disease. Sem Oncol 1985; 12: 32–35.
  • Le Chevalier T, Smith FP, Harter WK, Schein PS. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma. Sem Oncol 1985; 12: 46–53.
  • O’Connell M. Etoposide, doxorubicin, and cisplatinum chemotherapy for advanced gastric cancer: and old lesson revisited. J Clin Oncol 1992; 10: 515–516.
  • Comis RL, Carter SK. Integration of chemotherapy into combined modality treatment of solid tumors III, gastric cancer. Cancer Treat Rev 1974; 1: 221–238.
  • Schein PS, McDonald JS, Hott D, Wolley PV. Mitomycin C: experience in the United States with emphasis on gastric cancer. Cancer Chemother Pharmacol 1978; 1: 73–75.
  • Moertel CG, Lavine PT. Phase II-III chemotherapy studies in advanced cancer. Cancer Treat Rep 1979; 63: 1863–1869.
  • Bitran JD, Desser RK, Kozloff MF, Billings AR, Shapiro CM. Treatment of metastatic pancreatic and gastric carcinoma with 5- fluorouracil, adriamycin and mitomycin C (FAM). Cancer Treat Rep 1979; 63: 2049–2053.
  • MacDonald JS, Wooley PV, Smythe T, Uens W, Hott D, Schein PS. 5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in the treatment of ad-vanced gastric cancer. Cancer 1979; 44: 42–47.
  • MacDonald JS, Schein PS, Wooley PV et al. 5-Fluorouracil, doxorubicin, mitomycin C (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980; 93: 533–537.
  • Beretta G, Fraschini P, La Bianca R, Luporini G. The value of FAM polychemotherapy in advanced gastric carcinoma. Proc Am Soc Clin Oncol 1982; 1: 103.
  • Cersosimo RJ, Hong WK. Epirubicin: review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol 1986; 4: 425–430.
  • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
  • Haim M, Cohen Y, Honingham YJ, Robinson E. Treatment of advanced gastric carcinoma with 5-fluorouracil, adriamycin and mitomycin C (FAM). Cancer Chemother Pharmacol 1982; 8: 277–280.
  • Cunningham D, Soukop M, McArdle CS, et al. Advanced gastric cancer: experience in Scotland using the agents 5-fluorouracil, adriamycin, and mitomycin C. Proc. 13th Int. Congress of Chemotherapy, Vienna, 1983: part 259, pp. 1–2.
  • Kim NK, Park YS, Suh CI, Kang WK, Kim HT, Ileo DS. Phase III randomized comparison of 5FU versus FAM (5FU/ADM/MMC) versus FP (5FU/cisplatin) in patients with advanced gastric carcinoma. Proc Am Soc Clin Oncol 1991; 10: 441.
  • Wils JA, Klein HO, Wagener DJ, Bleiberg H, Reis H, Korsten F. Sequential high dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991; 9: 827–831.
  • Preusser H, Wilke H, Achterrath W et al. Phase II study with combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989; 7: 1310–1317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.